|
1. Aikawa, R., I. Komuro, et al. (1999). "Rho family small G proteins play critical roles in mechanical stress-induced hypertrophic responses in cardiac myocytes." Circ Res 84(4): 458-66.
2.Aoki, H., S. Izumo, et al. (1998). "Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation." Circ Res 82(6): 666-76.
3.Aznar, S., P. Fernandez-Valeron, et al. (2004). "Rho GTPases: potential candidates for anticancer therapy." Cancer Lett 206(2): 181-91.
4.Banyard, J., B. Anand-Apte, et al. (2000). "Motility and invasion are differentially modulated by Rho family GTPases." Oncogene 19(4): 580-91.
5.Bishop, A. L. and A. Hall (2000). "Rho GTPases and their effector proteins." Biochem J 348 Pt 2: 241-55.
6.Braga, V. M., L. M. Machesky, et al. (1997). "The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cell-cell contacts." J Cell Biol 137(6): 1421-31.
7.de Tombe, P. P. (2006). "Myosin binding protein C in the heart." Circ Res 98(10): 1234-6.
8.Dovas, A. and J. R. Couchman (2005). "RhoGDI: multiple functions in the regulation of Rho family GTPase activities." Biochem J 390(Pt 1): 1-9.
9.Fukata, Y., M. Amano, et al. (2001). "Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells." Trends Pharmacol Sci 22(1): 32-9.
10.Hart, M. J., Y. Maru, et al. (1992). "A GDP dissociation inhibitor that serves as a GTPase inhibitor for the Ras-like protein CDC42Hs." Science 258(5083): 812-5.
11.Hattori, T., H. Shimokawa, et al. (2004). "Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice." Circulation 109(18): 2234-9.
12.Hoffman, G. R., N. Nassar, et al. (2000). "Structure of the Rho family GTP-binding protein Cdc42 in complex with the multifunctional regulator RhoGDI." Cell 100(3): 345-56.
13.Hofmann, P. A., M. L. Greaser, et al. (1991). "C-protein limits shortening velocity of rabbit skeletal muscle fibres at low levels of Ca2+ activation." J Physiol 439: 701-15.
14.Hoshijima, M., V. P. Sah, et al. (1998). "The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase." J Biol Chem 273(13): 7725-30.
15.Jaffe, A. B. and A. Hall (2002). "Rho GTPases in transformation and metastasis." Adv Cancer Res 84: 57-80.
16.Kobayashi, N., S. Horinaka, et al. (2002). "Critical role of Rho-kinase pathway for cardiac performance and remodeling in failing rat hearts." Cardiovasc Res 55(4): 757-67.
17.Lin, G., G. P. Craig, et al. (2007). "Acute inhibition of Rho-kinase improves cardiac contractile function in streptozotocin-diabetic rats." Cardiovasc Res 75(1): 51-8.
18.Loirand, G., P. Guerin, et al. (2006). "Rho kinases in cardiovascular physiology and pathophysiology." Circ Res 98(3): 322-34.
19.Nobes, C. D. and A. Hall (1995). "Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia." Cell 81(1): 53-62. 20.Peters, S. L. and M. C. Michel (2007). "The RhoA/Rho kinase pathway in the myocardium." Cardiovasc Res 75(1): 3-4.
21.Rivero, F., D. Illenberger, et al. (2002). "Defects in cytokinesis, actin reorganization and the contractile vacuole in cells deficient in RhoGDI." EMBO J 21(17): 4539-49.
22.Sasaki, T. and Y. Takai (1998). "The Rho small G protein family-Rho GDI system as a temporal and spatial determinant for cytoskeletal control." Biochem Biophys Res Commun 245(3): 641-5.
23.Satoh, S., Y. Ueda, et al. (2003). "Chronic inhibition of Rho kinase blunts the process of left ventricular hypertrophy leading to cardiac contractile dysfunction in hypertension-induced heart failure." J Mol Cell Cardiol 35(1): 59-70.
24.Starr, R. and G. Offer (1978). "The interaction of C-protein with heavy meromyosin and subfragment-2." Biochem J 171(3): 813-6.
25.Tapper, J., E. Kettunen, et al. (2001). "Changes in gene expression during progression of ovarian carcinoma." Cancer Genet Cytogenet 128(1): 1-6.
26.Theodorescu, D., L. M. Sapinoso, et al. (2004). "Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer." Clin Cancer Res 10(11): 3800-6.
27.Wei, L., K. Imanaka-Yoshida, et al. (2002). "Inhibition of Rho family GTPases by Rho GDP dissociation inhibitor disrupts cardiac morphogenesis and inhibits cardiomyocyte proliferation." Development 129(7): 1705-14.
28.Winegrad, S. (1999). "Cardiac myosin binding protein C." Circ Res 84(10): 1117-26.
|